Background: The congenital malformation of the posterolateral portion of the diaphragm is called the Bochdalek hernia, and was first described in 1948 by anatomy professor Bochdalek. The diagnosis in adults is extremely rare, being in the majority, an occasional finding in a chest x-ray. Case:The authors report a Bochdalek Hernia case in an adult pacient, with complaints of dyspnea and epigastralgia refractory to pharmacological treatment. The diagnosis was confirmed after a chest CT scan. Conclusion:Bochdalek hernias are extremely rare in adults, commonly diagnosed in childhood. The importance of recognition of its diagnosis is crucial, so it should be always among differential diagnoses in radiology, due to the range of complications that may affect the patients.

No abstract

BACKGROUNDOsteoporosis (OP) is the most prevalent skeletal disease and can increase the risk of fracture. Within the pharmacological arsenal available for the control of OP, there are some options for subcutaneous (SC) use, such as denosumab (DNS), teriparatide (TER) and romosozumab (ROM). Adherence and persistence to treatment with SC use are influenced by age, cognition, needle anxiety, fear of losing medication and availability of a caregiver. The aim of this study was to evaluate the profile of patients using SC medication for OP and some factors that can impair the success of the treatment. METHODSAn observational, cross-sectional study was carried out through the application of a questionnaire to patients diagnosed with osteoporosis and using DNS and TER, followed up at the rheumatology's center of a tertiary hospital. RESULTForty-two patients were interviewed, 64% using DNS and 36% using ER, 95% being female, with an average age of 76.97 years. As expected, in TER (daily use medication), 100% were administered at home and only 13% of cases reported difficulty in application. In DNS (semestral medication), on the contrary, 74% of patients preferred application in a health unit (HU) for convenience or guidance from the medical team. In home cases (TER+DNS), 59% were applied by a caregiver and 41% were self-administered (p = 0.05). No statistical difference was found in relation to the delay in medication application among patients who used it at home or in a health unit (p = 0.59). The vast majority (90%) knew the correct way to store the medication in the refrigerator and 95% did not consider instability in the electrical network as a problem. CONCLUSIONThe choice of a SC medication must undergo a careful analysis of factors such as the convenience of choosing the place for application (home X HU), availability of a support individual (caregiver), in addition to intensive education of the patient and family regarding the various aspects of the chosen drug.

Background: Tuberculosis is an infectious disease caused by a bacillus called Mycobacterium tuberculosis or Koch's Bacillus (BK). It is associated with various long-term lung complications, including: lung scarring (fibrosis), bronchiectasis, Chronic Pulmonary Aspergillosis, and more rarely, atelectasis. There is however very limited data in literature on the full spectrum of these complications, and relies mostly on case reports and small case series. Case: The authors report a case of atelectasis in a patient with previous diagnosis of Tuberculosis. Normal laboratory tests and imaging test presenting right lung atelectasis. Went under respiratory therapy, presented improve and is under clinical control. Conclusion: There is a huge importance of knowing the various methods to diagnose this disease and treat it well. Thus, it enables an improvement in the patient and a reduction in the spread of bacteria.

Este é um artigo publicado em acesso aberto (Open Access) sob a licença Creative Commons Attribution Non-Commercial, que permite uso, distribuição e reprodução em qualquer meio, sem restrições desde que sem fins comerciais e que o trabalho original seja corretamente citado.